Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery
NCT: NCT07661589 · RECRUITING
Brief Summary
Spine surgery for scoliosis correction in pediatric patients is a major procedure associated with a high risk of perioperative blood loss. Homologous blood transfusion carries inherent risks, including immunological reactions, infections, and increased healthcare costs. Identifying high-risk patients is crucial to optimize blood conservation strategies. This retrospective study aims to identify preoperative and intraoperative risk factors associated with homologous red blood cell (RBC) transfusion and to evaluate the quantitative impact of Cell Saver volume reinfusion on reducing homologous transfusion requirements.
Frequently Asked Questions
What is Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery?
Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery is a clinical trial registered under NCT07661589. Current status: RECRUITING.
What is the status of NCT07661589?
The current status of NCT07661589 (Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery) is: RECRUITING.
When did Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery start?
Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery started on 2023-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.